Webinar – CEST MRI in Neurodegenerative Diseases
|Date & Time||November 6th, 2018|
|Tags||CEST-MRI, metabolic imaging, MRI, NEURATRIS, Neuro imaging, Neurodegenerative diseases, preclinical imaging|
Translational Metabolic Imaging using CEST MRI in Neurodegenerative Diseases
– Webinar powered by EATRIS and NEURATRIS
Chemical Exchange Saturation Transfer (CEST) imaging has emerged over the past decade as a new and innovative MRI contrast method, specifically designed for molecular imaging. CEST offers the possibility to detect a large variety of metabolites including glutamate, glucose, or creatine. This confers to CEST the potential to provide valuable clues about various pathological features in a single experiment.
In this webinar, Dr. Julien Flament of Molecular Imaging Research Center (MIRCen, CEA), Fontenay-aux-Roses, France, will introduce the theoretical background of CEST imaging and will illustrate its potential for translational research. He will outline how CEST has been introduced in both clinical and preclinical investigations. He will also provide an overview of how CEST works, the different options available with CEST, and also the theoretical considerations and future possibilities, particularly as they relate to degenerative diseases.
Dr. Julien Flament
Dr. Julien Flament is Permanent Researcher (UMR 9199) at Molecular Imaging Research Center (MIRCen, CEA, Fontenay-aux-Roses) since April 2012, where he is in charge of the Nuclear Magnetic Resonance platform. His personal research is focused on development of CEST imaging at very high magnetic field. Main objectives of MIRCen laboratory are to develop animal models of neurodegenerative diseases and to evaluate new therapeutic approaches. In this context, MRS, MRI and particularly CEST imaging are developed in order to use them as a valuable tools to monitor neurodegenerative disease. Dr. Julien Flament has dedicated his entire PhD thesis on CEST methods that are now routinely used at MIRCen to monitor disease progression in animal models on a state-of-the-art 7T and 11.7T scanners and high performance cryoprobe.
Please register for Translational Metabolic Imaging using CEST MRI in Neurodegenerative Diseases by Julien Flament on nov. 6, 2018 2:00 PM CET at:
After registering, you will receive a confirmation email containing information about joining the webinar.
This webinar is part of a series of 4 neuroimaging webinars jointly powered by EATRIS and NEURATRIS, covering the usage of CEST-MRI, optical imaging, PET and Ultrahigh Field MRI in neurodegenerative diseases and their potential application in translational medicine. For more information, please visit: https://eatris.eu/insights/neuroimaging-webinar-series-november/